← Tata Mutual Fund

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Equity Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
37
Apr 2026
Equity Holdings
₹1,319.60 Cr
Equity only, excl. debt & cash
Top 5 Weight
31.8%
Moderate
Top 10 Weight
52.6%
Moderate
Changes
35
0 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
58.7% of portfolio
📋 What Happened This Month Tata India Pharma & Healthcare Fund exited 1 stock from its portfolio this month. Krishna Institute Of Medical Sciences Limited was the biggest exit (Healthcare Services), which was held at 1.34%. Among existing holdings, Procter & Gamble Health Limited saw the biggest increase — now at 1.55% of the portfolio. Abbott India Limited was trimmed the most, now at 5.37%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 58.7%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

NAV Performance

1 year history · Tata India Pharma & Healthcare Fund-Direct Plan-Growth

1M
-0.36%
3M
+4.66%
6M
+1.75%
1Y
+6.40%
Latest NAV
₹36.51
04 Jun 2026
52W High
₹37.45
-3% from High
52W Low
₹30.72
+19% from Low
Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025
-3.5%
2024
+42.5%
2023
+38.6%
2022
-6.6%
2021
+20.9%
2020
+66.9%
2019
+7.2%
2018
-0.8%
2017
+6.4%
Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg
17.4%
+ve in 71% windows
78.8% / -18.0%
3Y Rolling Avg
18.5% p.a.
+ve in 91% windows
32.2% / -4.2%
5Y Rolling Avg
19.6% p.a.
+ve in 100% windows
31.6% / 8.7%
Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff
-16.8%
Rec: May 2026 (1yr 9mo)
COVID-19 Crash
-18.5%
Rec: Apr 2020 (1 mo)
2022 Rate Hike
-14.6%
Rec: Jun 2023 (1yr 5mo)
2018 IL&FS
-13.5%
Rec: Jan 2020 (1yr 10mo)
Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)
1.39
Return per unit of risk. >1 is good.
Sortino Ratio (3Y)
2.05
Penalises downside volatility only.
Std Deviation (3Y)
13.3%
Lower = more consistent returns.
NAV Chart ₹36.51 04 Jun 2026
Simple Moving Avg: Click to draw · click again to remove
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Chart shows indexed performance (base = 100). Actual NAV: ₹36.51
Sector Shift Industry allocation month-over-month
Feb 2026 → Mar 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 56.3% 58.7% ▲ +2.4%
Healthcare Services 37.9% 35.4% ▼ -2.6%
Fertilizers & Agrochemicals 3.3% 4.5% ▲ +1.2%
Insurance 0.0% 0.6% ▲ +0.6%
Chemicals & Petrochemicals 0.0% 0.5% ▲ +0.5%
Healthcare Equipment & Supplies 0.0% 0.0% ● 0.0%
Mar 2026 → Apr 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 58.7% 58.7% ● +0.0%
Healthcare Services 35.4% 35.0% ▼ -0.3%
Fertilizers & Agrochemicals 4.5% 4.5% ● -0.1%
Chemicals & Petrochemicals 0.5% 0.7% ▲ +0.2%
Insurance 0.6% 0.7% ● +0.1%
🔴
Biggest Exit
Krishna Institute Of Medical Sciences Limited
1.34% was held · Healthcare Services
↑
Biggest Add
Procter & Gamble Health Limited
+0.85% · now 1.55%
↓
Biggest Trim
Abbott India Limited
-0.52% · now 5.37%
👋 Other funds also exited
Krishna Institute Of Medical Sciences Limited 3 funds
Krishna Institute Of Medical Sciences Limited
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH
SBI Long Term Advantage Fund - Series VI - Direct Plan - Growth
ICICI Prudential ELSS Tax Saver Fund - Direct Plan - Growth

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 → Apr 2026
🔴 1 Exit ↑ 22 Increased ↓ 12 Decreased
#StockSectorLast Weight (Mar 2026)
1
Krishna Institute Of Medical Sciences Limited
₹16.48 Cr
 Healthcare Services 1.34%
#StockSectorMar 2026Apr 2026Change
1
Procter & Gamble Health Limited
₹20.48 Cr
 Pharmaceuticals & Biotechnology 0.70% 1.55% +0.85%
2
Fortis Healthcare Limited
₹47.01 Cr
 Healthcare Services 3.17% 3.55% +0.38%
3
Neuland Laboratories Limited
₹31.90 Cr
 Pharmaceuticals & Biotechnology 2.08% 2.41% +0.33%
4
Vijaya Diagnostic Centre Limited
₹22.74 Cr
 Healthcare Services 1.41% 1.72% +0.31%
5
Syngene International Limited
₹38.96 Cr
 Healthcare Services 2.64% 2.94% +0.30%
6
GlaxoSmithKline Pharmaceuticals Limited
₹32.37 Cr
 Pharmaceuticals & Biotechnology 2.14% 2.44% +0.30%
7
Dr. Reddy's Laboratories Limited
₹49.41 Cr
 Pharmaceuticals & Biotechnology 3.45% 3.73% +0.28%
8
Tata Chemicals Limited
₹9.51 Cr
 Chemicals & Petrochemicals 0.50% 0.72% +0.22%
9
Mankind Pharma Limited
₹49.43 Cr
 Pharmaceuticals & Biotechnology 3.57% 3.73% +0.16%
10
Global Health Limited
₹28.66 Cr
 Healthcare Services 2.01% 2.16% +0.15%
#StockSectorMar 2026Apr 2026Change
1
Abbott India Limited
₹71.10 Cr
 Pharmaceuticals & Biotechnology 5.89% 5.37% -0.52%
2
Aurobindo Pharma Limited
₹9.28 Cr
 Pharmaceuticals & Biotechnology 1.20% 0.70% -0.50%
3
Sun Pharmaceutical Industries Limited
₹130.76 Cr
 Pharmaceuticals & Biotechnology 10.34% 9.87% -0.47%
4
Lupin Limited
₹38.91 Cr
 Pharmaceuticals & Biotechnology 3.18% 2.94% -0.24%
5
Apollo Hospitals Enterprise Limited
₹53.83 Cr
 Healthcare Services 4.25% 4.06% -0.19%
6
JB Chemicals & Pharmaceuticals Limited
₹29.26 Cr
 Pharmaceuticals & Biotechnology 2.40% 2.21% -0.19%
7
Bayer Cropscience Limited
₹44.22 Cr
 Fertilizers & Agrochemicals 3.51% 3.34% -0.17%
8
Ajanta Pharma Limited
₹25.24 Cr
 Pharmaceuticals & Biotechnology 2.04% 1.90% -0.14%
9
Dr. Lal Path Labs Limited
₹34.46 Cr
 Healthcare Services 2.69% 2.60% -0.09%
10
Torrent Pharmaceuticals Limited
₹13.43 Cr
 Pharmaceuticals & Biotechnology 1.10% 1.01% -0.09%

Full Portfolio

37 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
Sun Pharmaceutical Industries Limited
₹130.76 Cr
 Pharmaceuticals & Biotechnology
9.87%
2
Divi's Laboratories Limited
₹78.42 Cr
 Pharmaceuticals & Biotechnology
5.92%
3
Healthcare Global Enterprises Limited
₹72.24 Cr
 Healthcare Services
5.45%
4
Abbott India Limited
₹71.10 Cr
 Pharmaceuticals & Biotechnology
5.37%
5
Max Healthcare Institute Limited
₹68.57 Cr
 Healthcare Services
5.17%
6
Cipla Limited
₹67.15 Cr
 Pharmaceuticals & Biotechnology
5.07%
7
Rainbow Childrens Medicare Limited
₹55.99 Cr
 Healthcare Services
4.23%
8
Apollo Hospitals Enterprise Limited
₹53.83 Cr
 Healthcare Services
4.06%
9
Mankind Pharma Limited
₹49.43 Cr
 Pharmaceuticals & Biotechnology
3.73%
10
Dr. Reddy's Laboratories Limited
₹49.41 Cr
 Pharmaceuticals & Biotechnology
3.73%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 Tata Mutual Fund — Portfolio & Holdings
See all funds managed by Tata Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.